Devaveena Dey

1.9k total citations
25 papers, 1.5k citations indexed

About

Devaveena Dey is a scholar working on Molecular Biology, Rheumatology and Surgery. According to data from OpenAlex, Devaveena Dey has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Rheumatology and 8 papers in Surgery. Recurrent topics in Devaveena Dey's work include Heterotopic Ossification and Related Conditions (9 papers), Tissue Engineering and Regenerative Medicine (5 papers) and Pluripotent Stem Cells Research (4 papers). Devaveena Dey is often cited by papers focused on Heterotopic Ossification and Related Conditions (9 papers), Tissue Engineering and Regenerative Medicine (5 papers) and Pluripotent Stem Cells Research (4 papers). Devaveena Dey collaborates with scholars based in United States, India and United Kingdom. Devaveena Dey's co-authors include Joseph C. Wu, Annapoorni Rangarajan, Mei Huang, Verónica Sánchez-Freire, Paul B. Yu, Joseph Gold, Kazuki Kodo, Thomas A. Davis, Suruchi Mittal and Won Hee Lee and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Devaveena Dey

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devaveena Dey United States 18 855 359 335 272 215 25 1.5k
Eric Hesse Germany 24 1.3k 1.5× 179 0.5× 350 1.0× 484 1.8× 436 2.0× 64 2.2k
Satoru Otsuru United States 26 750 0.9× 304 0.8× 408 1.2× 242 0.9× 205 1.0× 65 2.1k
Weiqi Lei United States 10 805 0.9× 193 0.5× 199 0.6× 429 1.6× 154 0.7× 11 1.6k
Agnes D. Berendsen United States 16 779 0.9× 340 0.9× 215 0.6× 207 0.8× 197 0.9× 21 1.5k
Motomi Enomoto‐Iwamoto United States 18 786 0.9× 1.2k 3.3× 332 1.0× 185 0.7× 257 1.2× 21 1.9k
Brya G. Matthews New Zealand 24 786 0.9× 299 0.8× 332 1.0× 387 1.4× 107 0.5× 54 1.8k
Ugur M. Ayturk United States 21 671 0.8× 350 1.0× 768 2.3× 303 1.1× 182 0.8× 34 1.9k
Martine Deckers Netherlands 12 1.0k 1.2× 210 0.6× 303 0.9× 495 1.8× 225 1.0× 18 1.9k
Kanji Mori Japan 26 768 0.9× 451 1.3× 1.0k 3.0× 482 1.8× 240 1.1× 126 2.6k
Girish Ramaswamy United States 12 428 0.5× 184 0.5× 201 0.6× 149 0.5× 268 1.2× 14 1.1k

Countries citing papers authored by Devaveena Dey

Since Specialization
Citations

This map shows the geographic impact of Devaveena Dey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devaveena Dey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devaveena Dey more than expected).

Fields of papers citing papers by Devaveena Dey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devaveena Dey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devaveena Dey. The network helps show where Devaveena Dey may publish in the future.

Co-authorship network of co-authors of Devaveena Dey

This figure shows the co-authorship network connecting the top 25 collaborators of Devaveena Dey. A scholar is included among the top collaborators of Devaveena Dey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devaveena Dey. Devaveena Dey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Eleanor, Jana Bagarova, Georgina Kerr, et al.. (2021). Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva. JCI Insight. 6(8). 41 indexed citations
2.
Edwards, Nicole, Devaveena Dey, Archie L. Overmann, et al.. (2021). High Frequency Spectral Ultrasound Imaging Detects Early Heterotopic Ossification in Rodents. Stem Cells and Development. 30(9). 473–484. 6 indexed citations
3.
Slaven, Sean E., Devaveena Dey, Kyle E. Nappo, et al.. (2021). Longitudinal Analysis of Circulating Markers of Bone Turnover Across Multiple Decades in Osteoporotic Women. The Journal Of Hand Surgery. 47(1). 85.e1–85.e10. 2 indexed citations
4.
Dey, Devaveena, Nicholas G. Fischer, Elsa Ronzier, et al.. (2021). Culture and characterization of various porcine integumentary-connective tissue-derived mesenchymal stromal cells to facilitate tissue adhesion to percutaneous metal implants. Stem Cell Research & Therapy. 12(1). 604–604. 5 indexed citations
5.
Hoyt, Benjamin W., et al.. (2021). Alarming Cargo: The Role of Exosomes in Trauma-Induced Inflammation. Biomolecules. 11(4). 522–522. 32 indexed citations
6.
Strong, Amy L., Philip Spreadborough, Devaveena Dey, et al.. (2020). BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma. Stem Cells and Development. 30(2). 91–105. 24 indexed citations
8.
Kooreman, Nigel G., Youngkyun Kim, Patrícia E. de Almeida, et al.. (2018). Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo. Cell stem cell. 22(4). 501–513.e7. 111 indexed citations
9.
Qureshi, Ammar T., Devaveena Dey, B. M. Wheatley, et al.. (2017). Inhibition of Mammalian Target of Rapamycin Signaling with Rapamycin Prevents Trauma-Induced Heterotopic Ossification. American Journal Of Pathology. 187(11). 2536–2545. 44 indexed citations
10.
Dey, Devaveena, B. M. Wheatley, David Cholok, et al.. (2017). The traumatic bone: trauma-induced heterotopic ossification. Translational research. 186. 95–111. 102 indexed citations
11.
Wheatley, B. M., Katherine E. Cilwa, Devaveena Dey, et al.. (2017). Palovarotene inhibits connective tissue progenitor cell proliferation in a rat model of combat‐related heterotopic ossification. Journal of Orthopaedic Research®. 36(4). 1135–1144. 16 indexed citations
12.
Dey, Devaveena, Jana Bagarova, Sarah Hatsell, et al.. (2016). Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification. Science Translational Medicine. 8(366). 366ra163–366ra163. 153 indexed citations
13.
Dey, Devaveena, David J. Goldhamer, & Paul B. Yu. (2015). Contributions of Muscle-Resident Progenitor Cells to Homeostasis and Disease. PubMed. 1(4). 175–188. 9 indexed citations
14.
Almeida, Patricia E. de, Everett Meyer, Nigel G. Kooreman, et al.. (2014). Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nature Communications. 5(1). 3903–3903. 123 indexed citations
15.
16.
Dey, Devaveena, Leng Han, Michael Bauer, et al.. (2013). Dissecting the Molecular Relationship Among Various Cardiogenic Progenitor Cells. Circulation Research. 112(9). 1253–1262. 76 indexed citations
17.
Ghosh, Zhumur, Mei Huang, Shijun Hu, et al.. (2011). Dissecting the Oncogenic and Tumorigenic Potential of Differentiated Human Induced Pluripotent Stem Cells and Human Embryonic Stem Cells. Cancer Research. 71(14). 5030–5039. 73 indexed citations
18.
Dey, Devaveena, Mohammed Inayathullah, Andrew S. Lee, et al.. (2011). Efficient gene delivery of primary human cells using peptide linked polyethylenimine polymer hybrid. Biomaterials. 32(20). 4647–4658. 52 indexed citations
19.
Mittal, Suruchi, Deepa Subramanyam, Devaveena Dey, Rekha V. Kumar, & Annapoorni Rangarajan. (2009). Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Molecular Cancer. 8(1). 128–128. 116 indexed citations
20.
Dey, Devaveena, Meera Saxena, Anurag N. Paranjape, et al.. (2009). Phenotypic and Functional Characterization of Human Mammary Stem/Progenitor Cells in Long Term Culture. PLoS ONE. 4(4). e5329–e5329. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026